Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON ALFA-2B for Chronic hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 77 adverse event reports in the FDA FAERS database where INTERFERON ALFA-2B was used for Chronic hepatitis c.

Most Reported Side Effects for INTERFERON ALFA-2B

Side Effect Reports % Deaths Hosp.
Product use in unapproved indication 224 10.8% 20 18
Off label use 207 10.0% 8 27
Fatigue 206 9.9% 5 26
Nausea 120 5.8% 4 20
Influenza like illness 105 5.1% 0 8
Drug ineffective 94 4.5% 7 10
Product use issue 86 4.1% 10 5
Headache 80 3.9% 0 13
Pyrexia 80 3.9% 6 33
No adverse event 76 3.7% 0 0
Adverse event 65 3.1% 2 24
Malaise 62 3.0% 2 23
Death 60 2.9% 59 13
Diarrhoea 57 2.8% 3 11
Decreased appetite 55 2.7% 3 17

Other Indications for INTERFERON ALFA-2B

Malignant melanoma (190) Hepatitis c (137) Cutaneous t-cell lymphoma (83) Mycosis fungoides (81) Product used for unknown indication (79) Bladder cancer (65) Covid-19 (43) Adult t-cell lymphoma/leukaemia (29) Chronic myeloid leukaemia (29) Neoplasm malignant (22)

Other Drugs Used for Chronic hepatitis c

RIBAVIRIN (15,707) PEGINTERFERON ALFA-2A (7,898) LEDIPASVIR\SOFOSBUVIR (6,621) SOFOSBUVIR\VELPATASVIR (6,405) SOFOSBUVIR (6,008) TELAPREVIR (3,103) GLECAPREVIR\PIBRENTASVIR (3,072) SIMEPREVIR (2,735) DACLATASVIR (2,063) PEGINTERFERON ALFA-2B (1,927)

Related Pages

INTERFERON ALFA-2B Full Profile All Chronic hepatitis c Drugs INTERFERON ALFA-2B Demographics INTERFERON ALFA-2B Timeline